glutathione cll | 70-18-8 Frontiers | Preclinical investigations of
Frontiers Preclinical investigations of the efficacy of the glutaminase inhibitor CB 839 alone and in combinations in chronic lymphocytic leukemia Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines Cell Death & Disease Targeting metabolic reprogramming in chronic lymphocytic leukemia Experimental Hematology & Oncology Springer Nature Link Glutathione: Lights and Shadows in Cancer Patients PMC Reduced Glutathione Complex Targeting the Ataxia Telangiectasia Mutated null phenotype in chronic lymphocytic leukemia with pro oxidants Haematologica
Pay in 4 interest-free payments of $5.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




